The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Biological subtype discordance after neoadjuvant therapy in early breast cancer: Findings from a 1,500-patient cohort with residual disease.
 
Katarzyna Pogoda
Honoraria - AstraZeneca; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Novartis; Sandoz
Speakers' Bureau - AstraZeneca; Gilead Sciences; Lilly Poland; Novartis; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Novartis
 
Magdalena Czopowicz
No Relationships to Disclose
 
Michal Czopowicz
No Relationships to Disclose
 
Agata Bak
No Relationships to Disclose
 
Wojciech Olszewski
No Relationships to Disclose
 
Monika Durzynska
Speakers' Bureau - Abbvie; Altium; AstraZeneca; GlaxoSmithKline; MSD
 
Dorota Najmrocka
No Relationships to Disclose
 
Paulina Halasa
No Relationships to Disclose
 
Elzbieta Brewczynska
Honoraria - AstraZeneca; Lilly; MSD; Novartis; Roche
 
Izabela Lemanska
Honoraria - AstraZeneca; Egis Pharmaceuticals; Lilly; MSD; Novartis; Pfizer; Roche
Speakers' Bureau - Lilly; Novartis
 
Anna Majstrak-Hulewska
Honoraria - AstraZeneca; Roche
 
Ewa Szombara
Honoraria - AstraZeneca; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Roche
Speakers' Bureau - Novartis
 
Zbigniew Nowecki
Honoraria - AstraZeneca; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche
 
Anna Niwinska
No Relationships to Disclose